Derek Hicks Net Worth & Insider Trades

Derek Hicks - EVP, Intellia Therapeutics, Inc

As of March 3, 2023

What is Derek Hicks's Net Worth?

The current estimated net worth of Intellia Therapeutics, Inc's EVP, Derek Hicks, is estimated to be about $919.23K . Derek Hicks owns about 17,306 units of Intellia Therapeutics, Inc common stock. In the last year at Intellia Therapeutics, Inc, Derek Hicks has sold an estimated value of $67.42K worth.

What is Derek Hicks's Past Insider Trading?

Derek Hicks's largest sale order was 1,812 units , worth over $67.42K on January 6, 2023. In total, Derek Hicks has made about 3 transactions over a year of their time at Intellia Therapeutics, Inc. Derek Hicks usually trades in January, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Derek Hicks's' Mailing Address?

  • Mailing address is C/o Intellia Therapeutics, Inc. 40 Erie Street Suite 130 Cambridge MA 02139 MA

Intellia Therapeutics, Inc Executive Compensation

Option Awards
Stock Awards
Other Compensation
John M. Leonard, M.D. 2020 $580,000 $319,000 $2,722,890 - $13,786 $3,635,676
John M. Leonard, M.D. 2019 $559,200 $307,560 - - $37,026 $903,786
John M. Leonard, M.D. 2018 $550,000 $302,500 $7,818,005 $1,011,713 $26,112 $9,708,330
Glenn G. Goddard 2020 $407,000 $146,520 $1,001,063 - $8,928 $1,563,511
Glenn G. Goddard 2019 $383,000 $153,200 - - $5,644 $541,844
Glenn G. Goddard 2018 $67,718 $51,652 $1,896,825 - $218 $2,016,413
David Lebwohl, M.D. 2020 $298,378 $228,000 $1,549,720 - $2,690 $2,078,788
Andrew D. Schiermeier, Ph.D. 2020 $455,400 $173,052 $1,081,148 - $8,928 $1,718,528
Andrew D. Schiermeier, Ph.D. 2019 $440,000 $167,200 $611,897 - $8,778 $1,227,875
Andrew D. Schiermeier, Ph.D. 2018 $408,934 $182,600 $2,028,554 $295,550 $9,668 $2,925,306
Laura Sepp-Lorenzino, Ph.D. 2020 $420,000 $184,800 $1,081,148 - $4,578 $1,690,526
Laura Sepp-Lorenzino, Ph.D. 2019 $239,487 $204,086 $1,318,695 - $221 $1,762,489
No matching records found


What are Intellia Therapeutics, Inc's Past Insider Trades?

Intellia Therapeutics, Inc's most recent insider trade came on August 2, 2023 by Muna Bhanji who sold 265 units worth $11.22K . In the last 7 years, insiders at Intellia Therapeutics, Inc have sold an estimated value of $307.39M and bought an estimated value of $44.06M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are John Leonard, President and CEO,  Francois Jean Formela, Director,  and Jose Rivera, EVP .

Intellia Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found